Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-03-12 Exercise | 2024-03-14 4:17 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO | 87,720 | $0 | 527,316 (Direct) | View |
2024-03-12 Tax Withholding | 2024-03-14 4:17 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO | 30,790 | $5.31 | 527,316 (Direct) | View |
2024-03-01 Exercise | 2024-03-05 4:56 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO | 138,826 | $0 | 1,296,960 (Direct) | View |
2024-03-04 Option Award | 2024-03-05 4:56 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO | 527,778 | $0 | 1,296,960 (Direct) | View |
2024-03-01 Tax Withholding | 2024-03-05 4:56 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO | 49,280 | $5.47 | 1,296,960 (Direct) | View |
2023-03-12 Exercise | 2023-03-14 4:30 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO | 87,719 | $0 | 468,560 (Direct) | View |
2023-03-03 Exercise | 2023-03-07 6:00 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO | 45,289 | $0 | 1,117,065 (Direct) | View |
2023-03-03 Option Award | 2023-03-07 6:00 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO | 688,074 | $0 | 1,117,065 (Direct) | View |
2023-03-01 Exercise | 2023-03-03 4:30 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO | 36,197 | $0 | 320,226 (Direct) | View |
2022-03-12 Exercise | 2022-03-15 5:30 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO | 87,719 | $0 | 387,074 (Direct) | View |
2022-03-01 Exercise | 2022-03-03 9:19 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO | 36,197 | $0 | 775,984 (Direct) | View |
2022-03-03 Option Award | 2022-03-03 9:19 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO | 543,477 | $0 | 775,984 (Direct) | View |
2021-11-09 Disposition | 2021-11-09 5:36 pm | N/A 2028-07-27 | Kadmon Holdings Inc. | KDMN | Konidaris Tasos Director | 50,000 | $6.15 | 0 (Direct) | View |
2021-11-09 Disposition | 2021-11-09 5:36 pm | N/A 2029-05-15 | Kadmon Holdings Inc. | KDMN | Konidaris Tasos Director | 100,000 | $7.21 | 0 (Direct) | View |
2021-11-09 Disposition | 2021-11-09 5:36 pm | N/A 2031-05-12 | Kadmon Holdings Inc. | KDMN | Konidaris Tasos Director | 116,370 | $5.92 | 0 (Direct) | View |
2021-11-09 Disposition | 2021-11-09 5:36 pm | N/A 2027-06-29 | Kadmon Holdings Inc. | KDMN | Konidaris Tasos Director | 50,000 | $5.38 | 0 (Direct) | View |
2021-11-09 Disposition | 2021-11-09 5:36 pm | N/A 2030-05-13 | Kadmon Holdings Inc. | KDMN | Konidaris Tasos Director | 102,040 | $5.06 | 0 (Direct) | View |
2021-05-12 Option Award | 2021-05-13 4:04 pm | N/A 2031-05-12 | Kadmon Holdings Inc. | KDMN | Konidaris Tasos Director | 116,370 | $0 | 116,370 (Direct) | View |
2021-03-12 Exercise | 2021-03-15 4:06 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO | 87,719 | $0 | 350,877 (Direct) | View |
2021-03-01 Option Award | 2021-03-03 5:03 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO | 434,364 | $0 | 434,364 (Direct) | View |
2020-05-13 Option Award | 2020-05-14 4:28 pm | 2021-05-13 2030-05-13 | Kadmon Holdings Inc. | KDMN | Konidaris Tasos Director | 102,040 | $0 | 102,040 (Direct) | View |
2020-03-12 Option Award | 2020-03-16 4:02 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos SVP and CFO | 1,052,631 | $0 | 1,052,631 (Direct) | View |